Literature DB >> 6874272

Efficacy of antifungal agents in the cornea. I. A comparative study.

D M O'Day, R Robinson, W S Head.   

Abstract

A standardized model of Candida albicans keratitis was developed in pigmented rabbits using a quantitative mycologic technique to evaluate the disease at intervals throughout the course. In this model, using two different infecting strains, the efficacy of five antifungal agents was compared. Amphotericin B, in concentrations of 0.5% to 0.075%, was superior to all other agents tested. Natamycin 5% ranked next, followed by 1% flucytosine, and 1% miconazole. Ketoconazole 1% was ineffective.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6874272

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

1.  Effect of itraconazole on the cornea in a murine suture model and penetrating keratoplasty model.

Authors:  Yang Kyung Cho; Eun Young Shin; Hironori Uehara; Balamurali Ambati
Journal:  Int J Ophthalmol       Date:  2017-11-18       Impact factor: 1.779

2.  Clinical results of topical fluconazole for the treatment of filamentous fungal keratitis.

Authors:  Sergio Sonego-Krone; Daniel Sanchez-Di Martino; Rosa Ayala-Lugo; Guillermo Torres-Alvariza; Christopher N Ta; Luciene Barbosa; Herminia Miño de Kaspar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-18       Impact factor: 3.117

3.  The effect of the ArF excimer laser on Candida albicans in vitro.

Authors:  J Frucht-Pery; M Mor; R Evron; A Lewis; H Zauberman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-07       Impact factor: 3.117

4.  Keratomycosis and amphotericin B.

Authors:  T O Wood; A W Tuberville; R Monnett
Journal:  Trans Am Ophthalmol Soc       Date:  1985

5.  Orally administered antifungal therapy for experimental keratomycosis.

Authors:  D M O'Day
Journal:  Trans Am Ophthalmol Soc       Date:  1990

6.  Mechanism underlying renal failure caused by pathogenic Candida albicans infection.

Authors:  Shin Jae-Chen; Jeon Young-Joo; Park Seon-Min; Seo Kang Seok; Shim Jung-Hyun; Chae Jung-Il
Journal:  Biomed Rep       Date:  2014-11-24

7.  Topical silver sulphadiazine--a new drug for ocular keratomycosis.

Authors:  M Mohan; S K Gupta; V K Kalra; R B Vajpayee; M S Sachdev
Journal:  Br J Ophthalmol       Date:  1988-03       Impact factor: 4.638

8.  Topical fluconazole for experimental candida keratitis in rabbits.

Authors:  W Behrens-Baumann; B Klinge; R Rüchel
Journal:  Br J Ophthalmol       Date:  1990-01       Impact factor: 4.638

9.  Morphogenic and genetic differences between Candida albicans strains are associated with keratomycosis virulence.

Authors:  Xia Hua; Xiaoyong Yuan; Bradley M Mitchell; Michael C Lorenz; Denis M O'Day; Kirk R Wilhelmus
Journal:  Mol Vis       Date:  2009-07-30       Impact factor: 2.367

10.  Medical management approach to infectious keratitis.

Authors:  Nikhil S Gokhale
Journal:  Indian J Ophthalmol       Date:  2008 May-Jun       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.